Simplifying Downstream Processing for Complex Biologics (Sept 2026)

Downstream processing can be the cause of a bottleneck in manufacturing, particularly for complex biologics, leading to a need for simpler platform approaches. In this technical interview, we discuss solutions that are being deployed to address this complicated challenge and a new, more simplified approach for a diverse subset of non-mAb therapies.